Key findings
Visibility and risk with AI
Artificial Intelligence (AI) and Machine Learning (ML) solutions are being implemented throughout the supply chain across numerous teams and processes. Twenty-five per cent of respondents believe supply chain visibility and risk management have the greatest potential for improvements through AI and ML technologies.
AI Adolescence
The pharmaceutical supply chain appears to be midway through its AI and ML-led transformation, with 97% of respondents rating their organisation's AI/ML maturity level as either a 3 or 4 out of 5.
Goals and metrics a challenge
Heads of supply chain continue to be challenged by defining concrete and measurable sustainability goals and metrics. When asked, 80% said they currently have partially concrete goals with few defined measurable metrics.
Supplier collaboration divide
Pharmaceutical firms demonstrate a near-equal split in AI utilisation for supplier collaboration. While 53% leverage AI to enhance partnerships, 47% have yet to implement such solutions. This highlights varying perspectives on AI's value in optimising supply chain relationships.
Finding out what's working
AI appears to be having a rapid impact on supply chain operations. Inventory optimisation and customer service, each cited by 41% of respondents, alongside quality control and assurance at 40%, are the leading areas where AI has demonstrably improved performance within the last year.
Of respondents say they expect ROI on AI within the next five years.
A message from our producer:
"As we look to 2025 and beyond, the convergence of digital, sustainable, and collaborative supply chains is accelerating. What’s exciting—and I hear this echoed by senior leaders—is the shift from reacting to disruptions to designing supply chains that can pre-empt and adapt to change. LogiPharma continues to be a key forum for these conversations. As the world’s leading life sciences supply chain event we’re driving the connections and insights that shape the future of our industry."
Will Robinson, Conference Director, LogiPharma
